When people are concerned about the timeline of prescription Zofran, they are typically concerned about 2 potential Zofran timelines. The first would be the Zofran timeline which describes the process of scrutiny by the scientific community leading ultimately to the potential Zofran recall. The other Zofran timeline relates to the timing with which Zofran is most likely to cause birth defects in pregnant mothers. This article is primarily concerned with shedding light on the Zofran recall timeline, but please view the other Zofran lawsuit material here to gain a better understanding of potential Zofran birth defects and a potential Zofran Lawsuit.
Free Case Review by Zofran Lawyer – Call 1-800-883-9858
Working backwards, a Swedish released in August of 2014 revealed information about increased Zofran birth defects risks. The Zofran report described that there may be significantly increased risk of cardiac defects in the children of mothers who took Zofran, especially during the first trimester of pregnancy.
Also in 2014, researchers declared that previous data suggesting that Zofran crosses into the fetus during pregnancy in high amounts was accurate. The study claimed that unborn infants may be affected by Zofran use during pregnancy after only 3 Zofran doses. This revelation is critical to the belief that Zofran may cause birth defects during pregnancy because it establishes proof that prescription Zofran can impact the unborn infant.
During August of 2013, two scientific papers about Zofran birth defects were brought forth to the International Society of Pharmacoepidemiology. The preliminary paper makes various claims related to Zofran. The next study released gathered data from additional sources of Zofran registries and determined that there can be a doubled risk of heart defects caused by taking Zofran during pregnancy. The Zofran timelines of these papers brought to light significant concerns about the safety of taking prescription Zofran during all or part of pregnancy.
Back in 2012, GlaxoSmithKline, the manufacturer of Zofran admitted guilt to a criminal health care fraud charge which stated that it violated a legislative act with 3 of its prescription drugs. GlaxoSmithKline agreed to pay criminal penalties as well as $2 billion in civil charges related to a lawsuit which claimed that GlaxoSmithKline marketed prescription Zofran for use among pregnant mothers suffering from morning sickness. The harm in this practice was that Zofran was only approved by the Food and Drug Administration to treat nausea caused by chemotherapy and operation, Zofran was not approved for use by the Food and Drug Administration (FDA) to treat pregnant women.
If you took Zofran during all or part of pregnancy and your child was born with a cleft lip or palate or a serious heart defect, then call for a Free & Confidential Zofran Lawsuit Evaluation as you and your child may have a legal right to significant monetary compensation for damages, medical expenses and other injuries.
Talk to a Board Certified Personal Injury Trial Lawyer licensed in Texas and in New York with a National Presence with the Highest Peer Review Rating. All Zofran birth defect cases are taken on a contingency fee basis and the client is never charged an attorney fee or any legal case expenses unless a recovery is obtained. (No Attorneys Fees or Lawyer Expenses Charged, Unless a Recovery is Made)
To contact a lawyer to discuss a potential Zofran Side Effect Lawsuit or call us Toll Free 1-800-883-9858